Clinical Trial Update: Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of iR2 in untreated and unfit elderly patients with Diffuse Large B-Cell Lymphoma is reported as a tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• iR2

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN